Rare disease company Eloxx raises $50M, lists on NASDAQ

Rare and ultra-rare premature stop codon diseases company Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX) raised $50 million in an April 26 follow-on and began trading on NASDAQ. The company sold 5.1 million shares at $9.75. Citigroup, Piper Jaffray, Canaccord Genuity and SunTrust Robinson Humphrey underwrote the offering...